Copyright
©The Author(s) 2024.
World J Gastroenterol. Jul 21, 2024; 30(27): 3326-3335
Published online Jul 21, 2024. doi: 10.3748/wjg.v30.i27.3326
Published online Jul 21, 2024. doi: 10.3748/wjg.v30.i27.3326
Figure 2 Treatment and follow-up of a patient with grade III internal hemorrhoids.
A: Internal hemorrhoids with prolapse; B and C: Endoscopic foam sclerobanding (EFSB); D: 12 months after EFSB without apparently prolapse; E: Formation of scars (arrow) in retroflexed; F: Formation of scars (arrow) in normal position.
- Citation: Qu CY, Zhang FY, Wang W, Gao FY, Lin WL, Zhang H, Chen GY, Zhang Y, Li MM, Li ZH, Cai MH, Xu LM, Shen F. Endoscopic polidocanol foam sclerobanding for the treatment of grade II-III internal hemorrhoids: A prospective, multi-center, randomized study. World J Gastroenterol 2024; 30(27): 3326-3335
- URL: https://www.wjgnet.com/1007-9327/full/v30/i27/3326.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i27.3326